James Schenck is an Analyst at Catalio Capital Management, LP. focused on public equity investments in the MedTech, Healthcare Services, Genomics, and Tools and Diagnostics sectors.
Prior to joining Catalio, James was an Analyst at HealthCor Management, LP. , a global healthcare-focused long/short equity fund, where he was responsible for recommending and managing public equity positions. Earlier in his career, James was an Investment Banking Analyst covering Healthcare at Morgan Stanley in New York.
James holds a Bachelor of Arts with High Honors in Economics from Dartmouth College.